Skip to main content

Table 2 The diagnostic performance of occurrence of 4 key clinical presentations for human African trypanosomiasis (HAT) diagnosis

From: Performance of clinical signs and symptoms, rapid and reference laboratory diagnostic tests for diagnosis of human African trypanosomiasis by passive screening in Guinea: a prospective diagnostic accuracy study

Number of signs or symptoms present

% Sensitivity (n/N, 95% CI)

% Specificity (n/N, 95% CI)

% PPV (n/N, 95% CI)

% NPV (n/N, 95% CI)

% Accuracy (n/N, 95% CI)

≥ 1/4

97.9 (47/48, 88.9–99.9)

75.6 (1737/2297, 73.8–77.4)

7.7 (47/607, 5.7–10.2)

99.9 (1737/1738, 99.7–100)

76.1 (1784/2345, 74.3–77.8)

 ≥ 2/4

87.5 (42/48, 74.8–95.3)

97.2 (2232/2297, 96.4–97.8)

39.3 (42/107, 30.1–49.2)

99.7 (2232/2238, 99.4–99.9)

97.0 (2274/2345, 96.2–97.6)

≥ 3/4

56.3 (27/48, 41.2–70.5)

99.7 (2289/2297, 99.3–99.9)

77.1 (27/35, 59.9–89.6)

99.1 (2298/2310, 98.6–99.4)

98.8 (2316/2345, 98.2–99.2)

4/4

18.8 (9/48, 9.0–32.6)

100 (2297/2297, 99.8–100)

100 (9/9, 66.4–100)

98.3 (2297/2336, 97.7–98.8)

98.3 (2306/2345, 97.7–98.8)

  1. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of occurrence of presence of enlarged lymph nodes in the neck and/or important weight loss and/or severe itching, and/or motor disorders were determined for identification of HAT patients. The occurrence of at least one symptom or sign (≥ 1/4) and co-occurrence (≥ 2/4; ≥ 3/4 or all 4/4) of the 4 selected clinical presentations was counted in 48 HAT patients and 2297 non-HAT affected study participants, and proportions (n/N) with 95% confidence intervals (CI) were determined